You just read:

Arena Pharmaceuticals Announces First Subject Dosed in ADVISE Phase 2 Trial Evaluating Etrasimod in Atopic Dermatitis

News provided by

Arena Pharmaceuticals, Inc.

Oct 28, 2019, 08:30 ET